INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Inhaled drug tested to help breathing in serious lung condition
Disease control CompletedThis study tested an inhaled drug called treprostinil in people with high blood pressure in their lungs caused by scarring lung disease. Researchers wanted to understand how the drug helps during exercise and affects quality of life after three months of use. The study involved 2…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Inhaled therapy tested for rare Double-Lung condition
Disease control CompletedThis study tested whether an inhaled medication called treprostinil could help people with sarcoidosis who have two related lung problems: scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). The goal was to see if this targeted, inh…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for scleroderma patients with lung damage
Disease control CompletedThis completed Phase 3 trial tested whether adding intravenous cyclophosphamide to standard prednisone treatment could better stabilize or improve lung function in people with scleroderma-related lung scarring. The study involved 40 adults whose lung function had recently worsene…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New inhaled therapy tested to slow scarring lung disease
Disease control CompletedThis study tested whether an inhaled medication called treprostinil could help slow the decline of lung function in people with idiopathic pulmonary fibrosis (IPF), a serious scarring lung disease. About 600 participants were randomly assigned to receive either the active drug or…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Can walking workouts ease breathing struggles?
Symptom relief CompletedThis study tested whether a supervised exercise program could help people with pulmonary hypertension (PH) become more active and feel better. 97 adults with PH or a related lung disease were randomly assigned to either start exercise right away or begin with education classes. T…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC
-
New device aims to help scarred lungs breathe easier
Symptom relief CompletedThis study tested whether a special exercise device called 'Lung Boost' could help people with interstitial lung disease (ILD), a condition that scars the lungs. Researchers worked with 40 women with ILD to see if using the device improved their breathing, reduced their tiredness…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
Could a common stomach issue be secretly scarring your lungs?
Knowledge-focused CompletedThis study aimed to understand if a hiatal hernia, where part of the stomach pushes into the chest, might cause very early lung injury before any lung disease is diagnosed. Researchers compared 14 adults with a hiatal hernia to those without, looking for signs of stomach fluid in…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC